From the Agenda

Designing and conducting clinical trials for Biosimilars

2017-11-24 10:25

Dr. Ekkehard Brockstedt

TCM Biosimilars, Corp. Div. Medicine

Ekkehard Brockstedt is a clinical research professional with more than 18 years of experience in drug development from phase II-IV with a focus on biologics. He has led the conduct of global clinical trial programmes in multiple therapeutic areas such as immunology and inflammatory diseases (Rheumatoid Arthritis, Crohns disease, Ulcerative Colitis, Psoriasis) and cardio-metabolic diseases (Stroke, DVT).
Prior to joining Boehringer Ingelheim he has held various project leader positions in clinical research and R&D project management at PRA Health Sciences Inc., Sankyo Pharma GmbH as well as Schering AG.

Ekkehard holds an MSc in chemistry from the Freie Universität, Berlin, a PhD in biochemistry from the Technische Universität, Berlin (MDC-Berlin) and an MBA from the University of Edinburgh.